ClinConnect ClinConnect Logo
Search / Trial NCT07103512

Scalene Hold Relax Technique With Conventional Physical Therapy in Asthma

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 29, 2025

Trial Information

Current as of September 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at whether a special breathing technique called the scalene hold relax technique, when combined with regular physical therapy exercises, can help improve lung function in people with asthma. The goal is to see if adding this technique provides extra benefits compared to usual treatment alone.

The study is open to both men and women between the ages of 20 and 44 who have been diagnosed with allergic asthma. However, people with other health problems like heart disease, diabetes, or mental health conditions that might affect their ability to follow the study plan won’t be eligible. Participants will be asked to try the scalene hold relax technique along with conventional exercises, and the researchers will monitor any changes in their breathing and lung function. This study is not yet recruiting, but it aims to find new ways to help people manage asthma better through physical therapy.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient diagnosed with Allergic asthma
  • Both male and female will be included
  • Age between 20 to 44 years.
  • Exclusion Criteria:
  • Patient who do not provide consent
  • Patient with any comorbid condition such as cardiovascular disease diabetes or other chronic illness
  • Patient with any psychological condition that may interfere with participation or adherence to the study protocol

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Mānsehra, Khyber Pkahtoonkhwa, Pakistan

Patients applied

0 patients applied

Trial Officials

Muhammad Iqbal Tariq, PhD*

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported